Regulation of by protein degradation and transport.
通过蛋白质降解和运输进行调节。
基本信息
- 批准号:13043039
- 负责人:
- 金额:$ 29.89万
- 依托单位:
- 依托单位国家:日本
- 项目类别:Grant-in-Aid for Scientific Research on Priority Areas
- 财政年份:2001
- 资助国家:日本
- 起止时间:2001 至 2005
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
Sekiguchi has studied mechanisms of nuclear-cytoplasmic transport of macromolecuar complex, mainly on GTP binding protein Ran related proteins, RCC1, RRAG A/GTR1, DDX3. RCC1 is a chromatin binding protein and a Ran Guanine exchange factor. In this study, we found that Gtrlp interacts to Ran-binding protein, Yrb2p, ribosome biogenesis proteins, Rpcl9p and Nop8p. We also found that RRAG A interacts to GTP binding proteins, RRAG C and RRAG D, and a novel nucleolar protein, NOP132. We isolated hamster temperature-sensitive mutant of DDX3, an RNA DEAD-box helicase playing roles in ribosome biogenesis and translation. DDX3 turned out to play a role in cyclin A expression in hamster cells. Nakayama investigates mammalian Skp2 and Fbw7, which are F-box protein components of an SCF-type ubiquitin ligase. Fbw7 targets c-Myc, Notch, c-Jun, and cyclin E, all of which function to promote cell cycle, for ubiquitin-dependent proteolysis. Clinical evidence suggests that loss of Fbw7 function results i … More n cancer development. We generated mice deficient in Fbw7 and found that the embryos died in utero, manifesting marked abnormalities in vascular development. To investigate the role of Fbw7 in cell-cycle control during cellular differentiation, we have generated mice in which Fbw7 is ablated only in T-cell lineage (Fbw7 conditional knockout mice: CKO). We used two promoters for Cre-expressing transgenic lines, Lck-promoter and CD4-promoter. In both cases, thymic hyperplasia was observed in Fbw7 CKO with specific expansion of CD4+CD8+ population. In normal mice, T cells are mainly proliferated at CD4-CD8-stage, and cell cycle ceases at CD4+CD8+ stage, whereas cell cycle remained activated at CD4+CD8+ stage in Fbw7 CKO. In CD4+CD8+ stage of Fbw7 CKO, c-Myc and Notch highly accumulated, whereas cyclin E levels were unaffected. Fbw7 CKO mice are predisposed to lymphomas. These data suggest that Fbw7 is indispensable for the cell cycle arrest at CD4+CD8+ stage, and loss of Fbw7 results in lymphomatogenesis. Less
Sekiguchi研究了大分子复合物的核-胞质转运机制,主要研究GTP结合蛋白Ran相关蛋白,RCC1、RRAG A/GTR1,DDX3是染色质结合蛋白和Ran鸟嘌呤交换因子。 Gtrlp 与 Ran 结合蛋白、Yrb2p、核糖体生物发生蛋白、Rpcl9p 和 Nop8p 相互作用。 RRAG A 与 GTP 结合蛋白 RRAG C 和 RRAG D 以及一种新型核仁蛋白 NOP132 相互作用,我们分离出 DDX3 的仓鼠温度敏感突变体,这是一种在核糖体生物发生和翻译中发挥作用的 RNA DEAD-box 解旋酶。 Nakayama 研究了哺乳动物 Skp2 和 Fbw7,它们是细胞周期蛋白 A 的组成部分。 SCF 型泛素连接酶以 c-Myc、Notch、c-Jun 和细胞周期蛋白 E 为靶点,所有这些酶都具有促进细胞周期的作用,可进行泛素依赖性蛋白水解。我们培育了缺乏 Fbw7 的小鼠,发现胚胎在子宫内死亡,表现出血管发育的明显异常。在细胞分化过程中的细胞周期控制中,我们产生了仅在 T 细胞谱系中 Fbw7 被消除的小鼠(Fbw7 条件敲除小鼠:CKO),我们使用了表达 Cre 的转基因系的两个启动子:Lck 启动子和 CD4- 启动子。在这两种情况下,在 Fbw7 CKO 中观察到胸腺增生,并伴有 CD4+CD8+ 群体的特异性扩增。在正常小鼠中,T 细胞主要在CD4-CD8-阶段,细胞周期在CD4+CD8+阶段停止,而Fbw7 CKO的细胞周期在CD4+CD8+阶段保持激活。在Fbw7 CKO的CD4+CD8+阶段,c-Myc和Notch高度积累,而细胞周期蛋白E。 Fbw7 CKO 小鼠易患淋巴瘤。这些数据表明 Fbw7 对于细胞周期停滞是必不可少的。 CD4+CD8+ 阶段和 Fbw7 缺失导致淋巴瘤发生较少。
项目成果
期刊论文数量(136)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Mitogenic signalling and the p16INK4a/Rb pathway co-operate to enforce irreversible cellular senescence through activating ROS/PKC-δ signalling pathway.
有丝分裂信号和 p16INK4a/Rb 信号通路协同作用,通过激活 ROS/PKC-δ 信号通路来强制细胞不可逆衰老。
- DOI:
- 发表时间:2006
- 期刊:
- 影响因子:0
- 作者:Takahashi;A.;et. al.
- 通讯作者:et. al.
Miyamoto, A., Nakayama, K., Imaki, H., Hirose, S., Jiang, Y., Abe, M., Tsukiyama, T., Nagahama, H., Ohno, S., Hatakeyama, S., Nakayama, K.I: "Increased proliferation of B cells and auto-immunity in mice lacking protein kinase Cδ"Nature. 416. 865-869 (2002
宫本 A.、中山 K.、今木 H.、广濑 S.、江 Y.、阿部 M.、月山 T.、长滨 H.、大野 S.、畠山 S.、 Nakayama, K.I:“缺乏蛋白激酶 Cδ 的小鼠 B 细胞增殖和自身免疫增强”《自然》杂志 416. 865-869(2002 年)
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
Deletion of Cdknlb ameliorates hyperglycemia by maintaining Compensatory hyperinsulinemia in diabetic mice.
Cdknlb 的缺失通过维持糖尿病小鼠的代偿性高胰岛素血症来改善高血糖。
- DOI:
- 发表时间:2005
- 期刊:
- 影响因子:0
- 作者:Uchida;T.;et al.
- 通讯作者:et al.
Shirane, M., Nakayama, K.I.: "Inherent calcineurin inhibitor FKBP38 targets Bcl-2 to mitochondria and inhibits apoptosis"Nature Cell Biol. 5. 28-37 (2003)
Shirane, M., Nakayama, K.I.:“固有钙调神经磷酸酶抑制剂 FKBP38 将 Bcl-2 靶向线粒体并抑制细胞凋亡”《自然细胞生物学》。
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
Protrudin induces neurite formation by directional membrane trafficking
- DOI:10.1126/science.1134027
- 发表时间:2006-11-03
- 期刊:
- 影响因子:56.9
- 作者:Shirane, Michiko;Nakayama, Keiichi I.
- 通讯作者:Nakayama, Keiichi I.
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
SEKIGUCHI Takeshi其他文献
SEKIGUCHI Takeshi的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('SEKIGUCHI Takeshi', 18)}}的其他基金
Analysis of RagA, B/C, D in mTOR signal transduction system
mTOR信号转导系统中RagA、B/C、D分析
- 批准号:
21570007 - 财政年份:2009
- 资助金额:
$ 29.89万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Multifractal and it's application
多重分形及其应用
- 批准号:
10640184 - 财政年份:1998
- 资助金额:
$ 29.89万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Study on roles of RCC1 and nuclear small G proteins (Ran and RagA) in cell growth.
RCC1 和核小 G 蛋白(Ran 和 RagA)在细胞生长中的作用研究。
- 批准号:
10680673 - 财政年份:1998
- 资助金额:
$ 29.89万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
相似海外基金
Analysis of ubiquitin receptors on regulatory functions of protein degradation
泛素受体对蛋白质降解调节功能的分析
- 批准号:
24570160 - 财政年份:2012
- 资助金额:
$ 29.89万 - 项目类别:
Grant-in-Aid for Scientific Research (C)